Literature DB >> 5026856

Xenogeneic recognition of tumour spcific plasma membrane antigens derived from mouse lymphoma cells.

A Wolf, R K Barfoot, R A Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5026856      PMCID: PMC1407810     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  11 in total

1.  QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING CR-51-LABELLED TARGET CELLS.

Authors:  H WIGZELL
Journal:  Transplantation       Date:  1965-05       Impact factor: 4.939

2.  Passive immunity in mice against C57BL leukosis E.L. 4 by means of iso-immune serum.

Authors:  P A GORER; D B AMOS
Journal:  Cancer Res       Date:  1956-05       Impact factor: 12.701

3.  Preparation of lymphocyte-specific antibody from anti-lymphocyte serum.

Authors:  N Shigeno; U Hämmerling; C Arpels; E A Boyse; L J Old
Journal:  Lancet       Date:  1968-08-10       Impact factor: 79.321

4.  Preparation and purification of plasma membranes from murine lymphoma cells carrying tumour-specific antigenicity.

Authors:  A Wolf; P J Avis
Journal:  Transplantation       Date:  1970-01       Impact factor: 4.939

5.  Therapy of transplantable mouse leukaemias with antileukaemia sera.

Authors:  A E Reif; C A Kim
Journal:  Nature       Date:  1969-09-27       Impact factor: 49.962

6.  The activity of tolerant antileukemia sera. I. In vivo effects.

Authors:  E Levi; R Golden; R Zerubavel; J Fisher
Journal:  Cancer Res       Date:  1966-04       Impact factor: 12.701

7.  Antilymphocytic leukemic serum and chemotherapy in the treatment of murine leukemia.

Authors:  D G Miller; G Moldovanu; A Kaplan; S Tocci
Journal:  Cancer       Date:  1968-12       Impact factor: 6.860

8.  Treatment of a murine leukemia with spleen cells or sera from allogeneic mice immunized against the tumor.

Authors:  P Alexander; D I Connell; Z B Mikulska
Journal:  Cancer Res       Date:  1966-07       Impact factor: 12.701

9.  THE EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS ON CELLULAR AND SUBCELLULAR MEMBRANES.

Authors:  R HERBERMAN; C A STETSON
Journal:  J Exp Med       Date:  1965-04-01       Impact factor: 14.307

10.  The persistence of mouse iso-antibodies in vivo.

Authors:  D B AMOS
Journal:  Br J Cancer       Date:  1955-03       Impact factor: 7.640

View more
  5 in total

1.  Acquisition of proviral DNA of mouse mammary tumor virus in thymic leukemia cells from GR mice.

Authors:  R Michalides; E Wagenaar; J Hilkens; J Hilgers; B Groner; N E Hynes
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

2.  Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity.

Authors:  V Schirrmacher; R Heicappell
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

3.  Separation of a tumour specific transplantation-type antigen from the ascitic fluid of mice bearing a syngeneic lymphoma.

Authors:  A Wolf; K A Steele
Journal:  Br J Cancer       Date:  1975-06       Impact factor: 7.640

4.  Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor.

Authors:  R Evans; C K Grant; H Cox; K Steele; P Alexander
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

5.  Estimation in sera by radioimmunoassay of a specific membrane antigen associated with a murine lymphoma.

Authors:  A Wolf; K A Steele; P Alexander
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.